These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 36314034)

  • 1. Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches.
    Obi ON; Saketkoo LA; Russell AM; Baughman RP
    Front Med (Lausanne); 2022; 9():991783. PubMed ID: 36314034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental drugs for sarcoidosis.
    Obi ON; Saketkoo LA; Maier LA; Baughman RP
    J Autoimmun; 2024 Mar; ():103179. PubMed ID: 38548579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
    Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
    Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
    Mirsaeidi M; Baughman RP
    Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records.
    Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ
    Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis.
    Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ
    J Health Econ Outcomes Res; 2022; 9(1):90-100. PubMed ID: 35529249
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital.
    Johns CJ; Michele TM
    Medicine (Baltimore); 1999 Mar; 78(2):65-111. PubMed ID: 10195091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapeutic management of pulmonary sarcoidosis.
    Fazzi P
    Am J Respir Med; 2003; 2(4):311-20. PubMed ID: 14719997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repository corticotropin for Chronic Pulmonary Sarcoidosis.
    Baughman RP; Sweiss N; Keijsers R; Birring SS; Shipley R; Saketkoo LA; Lower EE
    Lung; 2017 Jun; 195(3):313-322. PubMed ID: 28353116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
    Kahlmann V; Janssen Bonás M; Moor CC; van Moorsel CHM; Kool M; Kraaijvanger R; Grutters JC; Overgaauw M; Veltkamp M; Wijsenbeek MS;
    BMC Pulm Med; 2020 Oct; 20(1):271. PubMed ID: 33076885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).
    Birnie D; Beanlands RSB; Nery P; Aaron SD; Culver DA; DeKemp RA; Gula L; Ha A; Healey JS; Inoue Y; Judson MA; Juneau D; Kusano K; Quinn R; Rivard L; Toma M; Varnava A; Wells G; Wickremasinghe M; Kron J
    Am Heart J; 2020 Feb; 220():246-252. PubMed ID: 31911261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis.
    Mata Salvador MC; Francesqui J; Sellarés J
    Expert Opin Pharmacother; 2024 Jul; ():1-8. PubMed ID: 38975682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment of sarcoidosis.
    Sellarés J; Francesqui J; Llabres M; Hernandez-Gonzalez F; Baughman RP
    Curr Opin Pulm Med; 2020 Sep; 26(5):591-597. PubMed ID: 32701680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory Sarcoidosis: A Review.
    El Jammal T; Jamilloux Y; Gerfaud-Valentin M; Valeyre D; Sève P
    Ther Clin Risk Manag; 2020; 16():323-345. PubMed ID: 32368072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future directions in sarcoidosis research: summary of an NHLBI working group.
    Martin WJ; Iannuzzi MC; Gail DB; Peavy HH
    Am J Respir Crit Care Med; 2004 Sep; 170(5):567-71. PubMed ID: 15142870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights in fibrotic pulmonary sarcoidosis.
    Comes A; Sofia C; Richeldi L
    Curr Opin Pulm Med; 2022 Sep; 28(5):478-484. PubMed ID: 35838359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic pharmacotherapy for pulmonary sarcoidosis.
    Llabres M; Brito-Zerón P; Ramos-Casals M; Sellares J
    Expert Opin Pharmacother; 2019 Aug; 20(11):1397-1404. PubMed ID: 31090462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy reviews: treatment of sarcoidosis.
    Fanburg BL
    Am J Hosp Pharm; 1979 Mar; 36(3):351-4. PubMed ID: 369368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.